PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.38
1 yrs 5 m
1%
364.10 Crs
1% on or before 1M, Nil after 1M
Large Growth
9.4
SIP 100 & Lumpsum 500
NA
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk